Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome | Zendy

John H. Alexander | Zendy; Renato D. Lópes | Zendy; Stefan James | Zendy; Rakhi Kilaru | Zendy; Yaohua He | Zendy; Puneet Mohan | Zendy; Deepak L. Bhatt | Zendy; Shaun G. Goodman | Zendy; Freek W.A. Verheugt | Zendy; Marcus Flather | Zendy; Kurt Huber | Zendy; Danny Liaw | Zendy; Steen Husted | Zendy; José LópezSendón | Zendy; Raffaele De Caterina | Zendy; Petr Janský | Zendy; Harald Darius | Zendy; Dragoş Vinereanu | Zendy; Jan H. Cornel | Zendy; Frank Cools | Zendy; Dan Atar | Zendy; José L. Leiva-Pons | Zendy; Matyàs Keltai | Zendy; Hisao Ogawa | Zendy; Prem Pais | Zendy; Alexander Parkhomenko | Zendy; Witold Rużyłło | Zendy; Rafael Díaz | Zendy; Harvey D. White | Zendy; Mikhail Ruda | Zendy; Margarida Geraldes | Zendy; Jack Lawrence | Zendy; Robert A. Harrington | Zendy; Lars Wallentin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

Author(s) -

John H. Alexander,

Renato D. Lópes,

Stefan James,

Rakhi Kilaru,

Yaohua He,

Puneet Mohan,

Deepak L. Bhatt,

Shaun G. Goodman,

Freek W.A. Verheugt,

Marcus Flather,

Kurt Huber,

Danny Liaw,

Steen Husted,

José LópezSendón,

Raffaele De Caterina,

Petr Janský,

Harald Darius,

Dragoş Vinereanu,

Jan H. Cornel,

Frank Cools,

Dan Atar,

José L. Leiva-Pons,

Matyàs Keltai,

Hisao Ogawa,

Prem Pais,

Alexander Parkhomenko,

Witold Rużyłło,

Rafael Díaz,

Harvey D. White,

Mikhail Ruda,

Margarida Geraldes,

Jack Lawrence,

Robert A. Harrington,

Lars Wallentin

Publication year - 2011

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1105819

Subject(s) - medicine , acute coronary syndrome , apixaban , cardiology , ticagrelor , aspirin , platelet aggregation inhibitor , clopidogrel , intensive care medicine , myocardial infarction , rivaroxaban , atrial fibrillation , warfarin

Apixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent ischemic events when added to antiplatelet therapy after an acute coronary syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research